Investor

Clarify's software platform includes consumer engagement apps, patient management tools, and a value-based performance insight generator.

The market comprised $98 million in revenue during 2017, and is beginning to move away from stand-alone devices or apps. 

Notable announced its Series A funding round led by F-Prime Capital Partners and Oak HC/FT to further develop its wearable AI voice assistant for doctors. 

At $1,495, the company's full-length smart mirror streams fitness classes and connects to wearable heart rate trackers. 

Santa Monica-based Headspace announced that it would be acquiring voice-enabled AI system Alpine.Ai for an undisclosed sum this morning. 

Rx.Health — a Mount Sinai Health System spinoff that has built an app prescription platform for enterprises — has raised $1.8 million in seed funding. According to a statement, the investment will help the company pursue new clients and support the launch of its digital therapeutics and patient engagement tool, Bulk Prescription. "We've seen a tremendous increase in the demand for our services and the landscape of potential clients has broadened. By integrating multiple evidence-based solutions under one digital medicine platform, we're making digital transformation simple and affordable," Andy Pfau, COO of Rx.Health, said in a statement. "In addition to health systems, we're now able to capitalize on the advanced discussions we're having with payers and accountable care organizations. These discussions always change the application of your products, which in turn naturally fuels R&D.” Rx.Health’s leading product is RxUniverse, an enterprise-level, HIPAA-compliant platform that connects with a system’s EHR and allows practitioners to efficiently prescribe various therapeutic apps. The platform is available on iOS and Android, can be customized for and by individual customers, and can be deployed in 90 days, according to the company. The spinoff’s newly launched offering, Bulk Prescription, looks to help care teams prescribe and deploy care plans and digital therapeutics en mass. Designed to help manage entire cohorts, it will also allow individual patients control their symptoms by facilitating immediate access to education, remote monitoring, or a digital therapeutic via a device. Data collected from these patients is then collected and fed back into the system’s EHR and care management systems. According to a statement, Rx.Health is planning to first roll out Bulk Prescription to providers caring for patient cohorts with certain chronic diseases. RxUniverse, on the other hand, is already live across a number of health systems in the US. "Rx.Health is expanding the model for patient care by extending care outside of the clinical setting and allowing health care systems to harness the power of digital health," Erik Lium, EVP of Mount Sinai Innovation Partners, said in a statement. "Rx.Health is a prime example of the innovative, patient-first discoveries valued by the Mount Sinai Health System and I look forward to seeing its expansion as a leader in digital medicine."

Fit4D, a New York City-based diabetes management platform, announced another round of funding to expand its innovation efforts. 

David Hoke, who focuses on healthcare for the retail giant, said he's never seen anyone code empathy.

The funding round is led by Ark Applications and PAR, and joined by Boston Celtics owner Wyc Grousbeck.

The Harvard University spinout also announced a partnership with Veritas Genomics.